Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2002
03/14/2002WO2001073092A3 Interspecific dianthus plant
03/14/2002WO2001073075A3 Muskmelon cucumis melo hydroperoxide lyase and uses thereof
03/14/2002WO2001068882A3 Methods for homologous recombination
03/14/2002WO2001068836A3 Methods and compositions for rna interference
03/14/2002WO2001068226A3 A method of sorting cells
03/14/2002WO2001066696A3 Stable cell lines resistant to apoptosis and nutrient stress and methods of making same
03/14/2002WO2001063286A3 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries
03/14/2002WO2001062969A3 Estrogen receptor alpha variants and methods of detection thereof
03/14/2002WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof
03/14/2002WO2001060978A3 In ovo activation of an avian egg in the shell
03/14/2002WO2001059129A3 Mammalian secreted group iii phospholipase a2
03/14/2002WO2001059126A3 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility
03/14/2002WO2001058921A9 Methods and compositions for generating angiostatin
03/14/2002WO2001057085A3 G-protein coupled receptors
03/14/2002WO2001055392A3 Nuclear hormone receptors
03/14/2002WO2001055358A3 Phosphodiesterases
03/14/2002WO2001051512A3 Human and parasite orphan receptor proteins
03/14/2002WO2001048162A3 Method for the production of vitamin a
03/14/2002WO2001044497A3 Protein kinase regulation
03/14/2002WO2001040472A3 Streptococcus pneumoniae antigens
03/14/2002WO2001036684A3 Mammalian toxicological response markers
03/14/2002WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions
03/14/2002WO2001023572A3 Polynucleotides and polypeptides encoded thereby
03/14/2002WO2001020031A3 Polymorphisms in a klotho gene
03/14/2002WO2000066743A9 Viral expression vectors
03/14/2002WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase
03/14/2002WO2000053742A9 Polynucleotides and proteins encoded thereby
03/14/2002WO2000050048A9 Bone marrow transplantation for hepatic regeneration and repair
03/14/2002WO1997003998A9 Modulators of the function of fas receptors and other proteins
03/14/2002US20020032918 Alteration of growth and adaptation under hypoxic conditions
03/14/2002US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals
03/14/2002US20020032914 Transgenic mice containing ubiquitin-specific protease 16 gene disruptions
03/14/2002US20020032913 Gene Search Vector and Gene Search Method
03/14/2002US20020032912 Detecting modulators of transcriotional activity; obtain genetically engineered cells, expose to modulators, evaluate reporter gene expression
03/14/2002US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media
03/14/2002US20020031831 Plasmid for use in vaccination and gene therapy
03/14/2002US20020031828 Culturing cells; obtain cells, inoculate culture broth, kill tissue generated from mammals, monitor culture
03/14/2002US20020031825 Ethanol as solvent, a sterol such as cholesterol acetate, and a soluble carboxylic acid as metabolic precursor of lipid fatty acids
03/14/2002US20020031824 Preferential migration of and association of progenitor cells; obtain cells, administer cells to human, detect preferential binding
03/14/2002US20020031800 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002US20020031798 Antibody recognizing human 25-hydroxyvitamin D3-1a-hydroxylase
03/14/2002US20020031792 Complexing with monoclonal antibodies
03/14/2002US20020031784 Anti-apo-B-48 monoclonal antibody, hybridoma producing the same, and method for measuring apo-B-48 using the same
03/14/2002US20020031757 Generation of preferential cells; obtain cell sample, propagate cells, recover cells
03/14/2002US20020031514 Method for induction of differentiation of osteoclasts
03/14/2002US20020031501 Cardiomyocytes for heart muscles damaged in heart attacks
03/14/2002US20020031500 Delivery of therapeutic biologicals from implantable tissue matrices
03/14/2002US20020031499 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
03/14/2002US20020031498 Culturing lineage committed human cells under liquid culture conditions, including replacement of liquid culture medium at a rate and for a time sufficient to obtain human lineage committed cells; skin, bone marrow replacements, therapy
03/14/2002US20020031497 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
03/14/2002US20020031494 Nucleic acids for reducing carbohydrate epitopes
03/14/2002DE10043227A1 Neuartiges entwicklungsbiologisches Gen Novel biological developmental gene
03/14/2002DE10042177A1 New acetylcholine receptor subunit, useful for identifying plant-protection and therapeutic agents, comprises segment of insect subunit inserted into vertebrate subunit
03/14/2002DE10041515A1 Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen Process for the production of ready, antigen-loaded or -unbeladener, cryopreserved mature dendritic cells
03/14/2002CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice
03/14/2002CA2422114A1 Novel human cancer/testis antigen and gene thereof
03/14/2002CA2421922A1 Proteases
03/14/2002CA2421912A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2421858A1 Reporter system for cell surface receptor-ligand binding
03/14/2002CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
03/14/2002CA2421783A1 Receptor in the edb fibronectin domain
03/14/2002CA2421760A1 G-csf analog compositions and methods
03/14/2002CA2421757A1 G-csf analog compositions and methods
03/14/2002CA2421386A1 Disease-resistant plants and method of constructing the same
03/14/2002CA2421324A1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor
03/14/2002CA2421274A1 Method for down-regulating ige
03/14/2002CA2421251A1 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
03/14/2002CA2421248A1 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
03/14/2002CA2421218A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2421215A1 Genetic engineering of syringyl-enriched lignin in plants
03/14/2002CA2421187A1 Family member of inhibitor of apoptosis proteins
03/14/2002CA2421155A1 Osteoclast-associated receptor
03/14/2002CA2421075A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2421027A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2419979A1 Mammalian genes; related reagents and methods
03/14/2002CA2419577A1 Manganese lipoxygenase
03/14/2002CA2418077A1 In vitro human angiogenesis model
03/14/2002CA2416940A1 Genes involved in isoprenoid compound production
03/13/2002EP1186661A1 Identification of the major capacitative calcium channel in antigen presenting cells and uses thereof
03/13/2002EP1186655A1 Packaging cell
03/13/2002EP1186617A1 Novel recombinant antibody, amino acid sequences of cdrs thereof and genes encoding the same
03/13/2002EP1186301A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/13/2002EP1185867A2 Method for separating cells using immunorosettes
03/13/2002EP1185707A1 Means for identifying the locus of a major resistance gene with respect to the virus of the rice yellow mottle virus and uses thereof
03/13/2002EP1185694A1 49 human secreted proteins
03/13/2002EP1185682A1 Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes
03/13/2002EP1185678A2 R1 protein from wheat and the use thereof for the production of modified strach
03/13/2002EP1185676A2 Rad51 from maize and use thereof
03/13/2002EP1185671A2 Rice sucrose synthase promoter
03/13/2002EP1185666A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
03/13/2002EP1185661A2 Bacteriophage rm 378 of a thermophilic host organism
03/13/2002EP1185656A1 Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes
03/13/2002EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
03/13/2002EP1185650A1 Head trauma induced cytoplasmatic calcium binding protein
03/13/2002EP1185649A2 The myostatin gene promoter and inhibition of activation thereof
03/13/2002EP1185648A2 Methods and compositions for inhibiting neoplastic cell growth
03/13/2002EP1185646A1 Recombinant nematode nicotinic receptor and uses
03/13/2002EP1185645A1 Adipocyte complement related protein homolog zacrp7
03/13/2002EP1185643A1 Adipocyte complement related protein homolog zacrp5
03/13/2002EP1185642A2 Compositions and methods for the treatment of tumor